Private Equity Leadership for 2025 – Waud Capital Partners’ Strategic Team Building

Waud Capital Partners’ recent promotion announcement signals the firm’s strategic positioning for the coming year. With the elevation of Tim Cremieux, Kyle Lattner, and Paul Sutphin to Partner roles and Mike Lehman to Principal, the Chicago-based private equity firm strengthens its leadership team as it prepares for new opportunities in 2025.

As Justin DuPere, Partner and Co-Head of the Software & Technology Group, stated in the announcement, “These promotions underscore our momentum going into 2025 as we look to deploy capital across key sectors. Our newly elevated leaders exemplify our talent-led, thesis-driven investment approach.”

This forward-looking perspective reflects the vision Reeve B. Waud established when founding the firm in 1993. By building teams with specialized expertise across healthcare and technology, Waud Capital enhances its ability to identify promising companies and implement effective value-creation strategies.

Healthcare Leadership for Emerging Opportunities

The promotions of Cremieux and Lattner strengthen Waud Capital’s Healthcare Group at a time when the industry continues to present compelling investment opportunities. Cremieux, who joined in 2017, has demonstrated his capabilities through the PharmAlliance platform investment and his support for portfolio companies including Apotheco and PromptCare.

Lattner, with the firm since 2013, brings a decade of experience to his new role, including his work on Senior Helpers and Mopec Group investments. His ongoing support for APDerm and Ivy Rehab highlights his ability to guide companies through growth phases and market challenges.

Mike Lehman’s promotion to Principal further enhances the Healthcare Group’s capabilities, positioning Waud Capital to capitalize on opportunities across various healthcare subsectors in the coming year.

Technology Expertise for a Digital Future

Paul Sutphin’s elevation to Partner in the Software & Technology Group complements Waud Capital’s healthcare focus. His work on Science Exchange and support for portfolio companies including Fusion Health, PracticeTek, and Sphere demonstrate his ability to identify promising technology companies and guide their development.

This concentration of technology expertise reflects Reeve Waud’s strategic decision to focus on this sector alongside healthcare. As digital transformation continues across industries, Waud Capital’s specialized knowledge positions it to identify companies that address emerging needs through innovative solutions.

Building on a Foundation of Excellence

“At Waud Capital, we firmly believe that exceptional people drive exceptional value, and it holds true in both our portfolio and firm,” Reeve Waud noted in the announcement. This commitment to excellence has driven the firm’s approach to both talent development and investment strategy throughout its history.

The newly promoted partners exemplify this philosophy, having demonstrated their capabilities through successful investments and portfolio company support. Their advancement ensures that Waud Capital maintains its institutional knowledge while positioning itself for continued growth across its target sectors.

Prepared for 2025 and Beyond

With enhanced leadership capabilities in both healthcare and technology groups, Waud Capital enters 2025 well-positioned to identify promising companies and implement effective value-creation initiatives. The firm’s talent-led, thesis-driven approach provides a framework for capitalizing on opportunities across its target sectors.